[1]
G. Gurevičienė, “THE PHARMACOKINETICS, EFFICACY, IMMUNOGENICITY, AND SAFETY OF ATEZOLIZUMAB SUBCUTANEOUS IN NON-SMALL-CELL LUNG CANCER. IMSCIN001 CLINICAL STUDY (PART 2)”, PIA, vol. 8, no. 2, pp. 214-218, Sep. 2024.